Published on:

Anadarko Petroleum CorporationPublicly available records indicate that a class action lawsuit has been filed on behalf of investors in Anadarko Petroleum Corporation (NYSE:APC) in connection to alleged violations of securities laws by APC. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in Anadarko Petroleum Corporation between February 17, 2016 and May 2, 2017.

The class action complaint specifically alleges that during the period in question, APC might have provided false and/or misleading material information, and/or failed to disclose adverse material information to the public, chiefly: that the company had insufficient safety and maintenance procedures governing certain of its vertical wells; that as a result of these inadequacies, the wells had a heightened risk of explosion; and that thus the company’s statements to the public were misleading and materially false during the relevant period. A home explosion close to an APC well killed two people and seriously injured a third on April 17, 2017; on April 26, the company announced it would cease operating 3,000 Colorado vertical wells in response to the explosion.

After this news came to light, APC declined $2.84/share, or 4.74%, from $59.96/share on April 26 to a close of $57.12/share on April 27. The Frederick-Firestone Fire Protection District announced on May 2, 2017 that a defective gas line at an APC well was connected to the explosion, with officials concluding that the gas line had not been disconnected from the well even though it was not actively being used. After this news came to light, APC fell $4.33/share, or 7.69%, from $56.28/share on May 2 to a close of $51.95/share on May 3, 2017.

Published on:

KBR Inc.Publicly available records indicate that a class action lawsuit has been filed on behalf of investors in KBR Inc. (NYSE:KBR) in connection to alleged violations of securities laws by KBR. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in KBR Inc. between February 26, 2016 through April 27, 2017.

The class action complaint specifically alleges that during the period in question, KBR might have provided false and/or misleading material information, and/or failed to disclose adverse material information to the public, chiefly: that the company’s subsidiaries in the United Kingdom had participated in violations of bribery and corruption laws; and that thus the company’s statements to the public were misleading and materially false during the relevant period. When the UK’s Serious Fraud Office disclosed, on April 28, 2017, that it was involved in an investigation of “the activities of KBR’s UK subsidiaries, their officers, employees and agents for suspected offences of bribery and corruption,” KBR declined in value $1.43/share, or more than 9%, to close at $14.05/share on that date.

According to the company’s website, KBR Inc. is “a global provider of differentiated professional services and technologies across the asset and program life cycle within the Government Services and Hydrocarbons sector.” The description continues: “KBR employs approximately 34,000 people worldwide (including our joint ventures), with customers in more than 80 countries, and operations in 40 countries, across three synergistic global businesses.”

Published on:

Synchronoss Technologies

Publicly available records indicate that a class action lawsuit has been filed on behalf of investors in Synchronoss Technologies (NASDAQ:SNCR) in connection to alleged violations of securities laws by SNCR. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in Synchronoss Technologies between May 6, 2016 through April 26, 2017.

The class action complaint specifically alleges that during the period in question, SNCR might have provided false and/or misleading material information, and/or failed to disclose adverse material information to the public, chiefly: that the company was going to be unable to reach the revenue guidance it had previously given its investors; that as a result of this, the company, was going to have to update that guidance; and that as a result, SNCR’s statements to the public about its operations, prospects and business were materially false and misleading and/or had no reasonable basis during the relevant period. When the market gained access to true details of the situation, according to the lawsuit, SNCR’s investors suffered damages.

According to the company’s website, Synchronoss Technologies “provides essential mobile solutions for Service Providers and Enterprise through proven and scalable software solutions and platforms.” The company’s description continues: “Ours is a powerful, secure, and frictionless new approach to modern mobility, one that simplifies the creation and management of customer and employee experiences associated with identity, cloud, messaging, applied analytics, and secure mobility. This approach enables our clients to transform their businesses by creating growth, profitability and competitive advantage. With 130+ seminal patents, Synchronoss has one of the largest, most comprehensive technology platforms in production, widely used by the largest service providers and their 3 billion-plus mobile subscribers located around the world.”

Published on:

ImmunoCellular TherapeuticsPublicly available records indicate that a class action lawsuit has been filed on behalf of investors in ImmunoCellular Therapeutics (NYSEMKT:IMUC) in connection to alleged violations of securities laws by IMUC. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in ImmunoCellular Therapeutics between May 1, 2012 and December 11, 2013.

The class action complaint specifically alleges that during the period in question, IMUC might have provided false and/or misleading material information, and/or failed to disclose adverse material information to the public, chiefly: that the company had retained the stock promotion firm Lindingo Holdings, LLC for the purpose of publishing materials that would promote the company, an unlawful act that gave the impression to the market that clinical studies for ImmonuCellular’s product candidate ICT-107 were in good shape. The Securities and Exchange Commission announced enforcement actions against IMUC on April 10, 2017, alleging the company participated in stock promotion schemes.

According to the company’s website, ImmunoCellular Therapeutics is “a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers.” The description continues: “The Company’s lead product candidate, ICT-107, is a patient-specific, dendritic cell-based immunotherapy targeting glioblastoma and is currently being studied in an international Phase 3 trial. ImmunoCellular’s pipeline also includes: ICT-121, a patient-specific, dendritic cell-based immunotherapy targeting CD133 found in recurrent glioblastoma; ICT-140, a patient-specific, dendritic cell-based immunotherapy targeting ovarian cancer; and the Stem-to-T-cell research program which engineers hematopoietic stem cells to generate cytotoxic T cells.”

Published on:

Ocwen Financial Corporation

Publicly available records indicate that a class action lawsuit has been filed on behalf of investors in Ocwen Financial Corporation (NYSE:OCN) in connection to alleged violations of securities laws by OCN. Fitapelli Kurta is interested in hearing from investors who have complaints regarding investments made in Ocwen Financial Corporation between May 11, 2015 and April 19, 2017.

The class action complaint specifically alleges that during the period in question, OCN might have provided false and/or misleading material information, and/or failed to disclose adverse material information to the public, chiefly: that the company participated in substantial and systemic violations of federal consumer financial law; that as a result, OCN’s statements to the public about its operations, prospects and business were materially false and/or misleading during the relevant period. When the Consumer Financial Protection Bureau announced on April 20, 2017 that it was suing OCN for violations of federal laws, the company’s value declined more than 53%, falling from $2.91/share to a close of $2.49/share on that day.

According to the company’s website, Ocwen Financial Corporation is “one of the largest mortgage companies in America with over 9,000 employees.” The company’s description continues: “Ocwen originates both traditional and reverse mortgage loans and specializes in helping families achieve their financial and homeownership goals. We also provide innovative automotive floorplan financing and commercial mortgage servicing solutions for business partners.”

Published on:

Robert RotunnoPublicly available records provided by the Financial Industry Regulatory Authority (FINRA) on May 20, 2017 indicate that New York-based National Securities broker Robert Rotunno has received several resolved or pending customer disputes. Fitapelli Kurta is interested in speaking to investors who have complaints regarding Mr. Rotunno (CRD# 4025263).

Robert Rotunno has spent 17 years in the securities industry and has been registered with National Securities in New York, New York since January 2016. Previous registrations include Laidlaw & Company in New York, New York; Sands Brothers in New York, New York; Global Capital in Englewood, Colorado; Murphy & Durieu in New York; New York; and American Investment Services in Oklahoma City, Oklahoma. He has passed two securities industry examinations: Series 63 (Uniform Securities Agent State Law Examination) and Series 7 (General Securities Representative Examination). He is a registered broker with 37 US states and territories.

According to his BrokerCheck report, he has received six customer complaints and two pending customer complaints.

Published on:

Michael GoldbergPublicly available records provided by the Financial Industry Regulatory Authority (FINRA) on May 20, 2017 indicate that New Jersey-based Morgan Stanley broker/adviser Michael Goldberg has received resolved or pending customer disputes. Fitapelli Kurta is interested in speaking to investors who have complaints regarding Mr. Goldberg (CRD# 1526794).

Michael Goldberg has spent 30 years in the securities industry and has been registered with Morgan Stanley in Short Hills, New Jersey since 2009. Previous registrations include Citigroup Global Markets in Short Hills, New Jersey (1993-2009) and Lehman Brothers in New York, New York (1986-1993). He has passed four securities industry examinations: Series 65 (Uniform Investment Adviser Law Examination); Series 63 (Uniform Securities Agent State Law Examination); Series 7 (General Securities Representative Examination); and Series 3 (National Commodity Futures Examination). He is a registered broker and investment adviser with 23 US states and territories.

According to his BrokerCheck report, he has received one customer complaint and one pending customer complaint.

Published on:

Kim Love

Publicly available records provided by the Financial Industry Regulatory Authority (FINRA) on May 20, 2016 indicate that Florida-based Summit Brokerage Services broker/adviser Kim Love has received a pending customer dispute. Fitapelli Kurta is interested in speaking to investors who have complaints regarding Ms. Love (CRD# 1242426).

Kim Love has spent 33 years in the securities industry and has been registered with Summit Brokerage Services in Boca Raton, Florida since 2005. Previous registrations include Wachovia Securities Financial Network in St. Louis, Missouri; JWGenesis Securities in Boca Raton, Florida; JW Charles Securities in Boca Raton, Florida; EF Hutton & Company; and Painewebber. She has passed four securities industry examinations: Series 65 (Uniform Investment Adviser Law Examination); Series 63 (Uniform Securities Agent State Law Examination); Series 7 (General Securities Representative Examination); and Series 24 (General Securities Principal Examination). She is a registered broker and investment adviser with 30 US states and territories.

According to her BrokerCheck report, she has received one pending customer complaint and one denied customer complaint.

Published on:

Charles CorrealPublicly available records published by the Financial Industry Regulatory Authority (FINRA) on May 20, 2017 indicate that Pennsylvania-based Harvest Financial Corporation broker/adviser Charles Correal has received several resolved or pending customer disputes. Fitapelli Kurta is interested in speaking to investors who have complaints regarding Mr. Correal (CRD# 1366202).

Charles Correal has spent 31 years in the securities industry and has been registered with Harvest Financial Corporation in Pittsburgh, Pennsylvania since May 2016. Previous registrations include Morgan Stanley in Upper St. Clair, Pennsylvania; Morgan Stanley & Company in Pittsburgh, Pennsylvania; Morgan Stanley DW in Pittsburgh, Pennsylvania; and Janney Montgomery Scott in Cannonsburg, Pennsylvania. He has passed two securities industry examinations: Series 63 (Uniform Securities Agent State Law Examination) and Series 7 (General Securities Representative Examination). He is a registered broker and investment adviser with nine US states and territories: Arizona, California, Florida, Maryland, Ohio, Pennsylvania, Texas, Virginia and West Virginia.

According to his BrokerCheck report, he has received one customer complaint and three pending customer complaints.

Published on:

Joe Buckner

Publicly available records provided by the Financial Industry Regulatory Authority (FINRA) on May 19, 2017 indicate that former Texas-based Brazos Securities broker/adviser Joe Buckner has been sanctioned by FINRA and barred from acting as a broker or otherwise associating with firms that sell securities to the public. Fitapelli Kurta is interested in speaking to investors who have complaints regarding Mr. Buckner (CRD# 2187957).

Joe Buckner has spent 21 years in the securities industry and was most recently registered with Brazos Securities in Dallas, Texas (1996-2015). Previous registrations include Maplewood Investment Advisors in Dallas, Texas; La Jolla Capital Corporation in San Diego, California; and Merrill Lynch in New York, New York. He is currently not registered with any state or firm.

According to his BrokerCheck report, he has received one FINRA sanction and one pending customer complaint, and has been named in a pending regulatory investigation.